A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies

British Journal of Haematology

Volumn 105, Issue 4, 1999, Pages 901-911

  Morgenstern, Godfrey R ^a   Prentice, Archibald G ^b   Prentice, H Grant ^c   Ropner, Janet E ^d   Schey, Stephen A ^e   Warnock, David W ^f  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^e GUY S HOSPITAL   (United Kingdom)

^f Public Health Laboratory   (United Kingdom)

Author keywords

Antifungal prophylaxis; Aspergillus; Candida; Fluconazole; Itraconazole

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLUS; CANDIDA ALBICANS; CANDIDA TROPICALIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOSIS; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG INTERACTIONS; FEMALE; FLUCONAZOLE; HEMATOLOGIC NEOPLASMS; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; MYCOSES; OPPORTUNISTIC INFECTIONS; VINCRISTINE;

EID: 0032991690     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01465.x     Document Type: Article

References (46)

1. Alangaden, G., Chandrasekar, P.H., Bailey, E. & Khaliq, Y. (1994) Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. Bone Marrow Transplantation, 14, 919-924.
2. Anaissie, E. (1992) Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clinical Infectious Diseases, 14, (Suppl. 1), S43-S53.
3. Anaissie, E.J., Kontoyiannis, D.P., Huls, C., Vartivarian, S.E., Karl, C., Prince, R.A., Bosso, J. & Bodey, G.P. (1995) Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections. Journal of Infectious Diseases, 172, 599-602.
4. Aversa, F., Tabilio, A., Velardi, A., Cunningham, I., Terenzi, A., Falzetti, F., Ruggeri, L., Barbabietola, G., Aristei, C., Latini, P., Reisner, Y. & Martelli, M.F. (1998) Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. New England Journal of Medicine, 339, 1186-1193.
5. Barnes, R.A. & Rogers, T.R. (1998) Response rates to a staged antibiotic regimen in febrile neutropenic patients. Journal of Antimicrobial Chemotherapy, 22, 759-763.
6. Behre, G., Schwartz, S., Heinemann, V., Hiddeman, W. & Beyer, J. (1997) Randomised trial of amphotericin B for prevention of invasive aspergillus infections in neutropenic patients. Blood, 90, (Suppl. 1), 598a.
7. Bodey, G., Bueltmann, B., Duguid, W., Gibbs, D., Hanak, H., Hotchi, M., Mall, G., Martino, P., Meunier, F. & Milliken, S. (1992) Fungal infections in cancer patients: an international autopsy study. European Journal of Clinical Microbiology and Infectious Diseases, 11, 99-109.
8. Bodey, G.P. (1994) Antifungal prophylaxis during remission induction therapy for acute leukemia: fluconazole versus intravenous amphotericin B. Cancer, 73, 2099-2106.
9. Böhme, A., Just-Nübling, G., Bergman, L., Shah, P.M., Stille, W. & Hoelzer, D. (1996) Itraconazole for prophylaxis of sustemic mycoses in neutropenic patents with haematological malignancies. Journal of Antimicrobial Chemotherapy, 38, 953-961.
10. Boogaerts, M.A., Verhoef, G.E., Zachee, P., Demuynck, H., Verbist, L. & De Beule, K. (1989) Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. Mycoses, 32, (Suppl. 1), 103-108.
11. Bradford, C.R., Prentice, A.G., Warnock, D.W. & Copplestone, J.A. (1991) Comparison of the multiple dose pharmacokinetics of two formulations of itraconazole during remission induction for acute myeloblastic leukaemia. Journal of Antimicrobial Chemotherapy, 28, 555-560.
12. Como, J.A. & Dismukes, W.E. (1994) Oral azole drugs as systemic antifungal therapy. New England Journal of Medicine, 330, 263-272.
13. Denning, D.W., Lee, J.Y., Hostetler, J.S., Pappas, P., Kauffman, C.A., Dewsnup, D.H., Galgiani, J.N., Graybill, J.R., Sugar, A.M. & Cantanzaro, A. (1994) NIAID Mycosis Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. American Journal of Medicine, 97, 135-144.
14. Denning, D.W., Tucker, R.M., Hanson, L.H. & Stevens, D.A. (1989) Treatment of invasive aspergillosis with itraconazole. American Journal of Medicine, 86, 791-800.
15. Denning, D.W., Tucker, R.M., Hanson, L.H. & Stevens, D.A. (1990) Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis. Journal of the American Academy of Dermatology, 23, 602-607.
16. Egger, T., Gratwohl, A., Tichelli, A., Uhr, M., Stebler Gysi, C., Passweg, J., Pless, M., Wernli, M., Buser, U., Wuhrmann, J., Frei, R., Nissen, C. & Speck, B. (1995) Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients: a prospective, randomized, single-center study. Supportive Care in Cancer, 3, 139-146.
17. Gallis, H.A., Drew, R.H. & Pickard, W.W. (1990) Amphotericin B: 30 years of clinical experience. Reviews of Infectious Diseases, 12, 308-329.
18. Goodman, J.L., Winston, D.J., Greenfield, R.A., Chandrasekar, P.H., Fox, B.F., Kaizer, H., Shadduck, R.K., Shea, T.C., Stiff, P. & Friedman, D.J. (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New England Journal of Medicine, 326, 845-851.
19. Gotzsche, P.C. & Krogh Johansen, H. (1997) Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia. British Medical Journal, 314, 1238-1244.
20. Groll, A.H., Shah, P.M., Mentzel, C., Schneider, M., Just-Nuebling, G. & Huebner, K. (1996) Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. Journal of Infection, 33, 23-32.
21. Jantunen, E., Ruutu, P., Niskanen, L., Volin, L., Parkkali, T., Koukila-Kähkölä, P. & Ruutu, T. (1997) Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplantation, 19, 801-808.
22. Kappe, R., Osterziel, K.J., Ruchel, R. & Siehl, S. (1993) Fluconazole in patients at risk from invasive aspergillosis. Journal of Medical and Veterinary Mycology, 31, 259-261.
23. Kelsey, S.M., Goldman, J.M., McCann, S., Newland, A.C., Scarffe, J.H., Oppenheim, B.A. & Mufti, G.J. (1999) Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infection in neutropenic patients: a randomised, double-blind, placebo-controlled study. Bone Marrow Transplantation, 23, 163-168.
24. Lyman, C.A. & Walsh, T.J. (1992) Systemically administered anti-fungal agents: a review of their clinical pharmacology and therapeutic applications. Drugs, 44, 9-35.
25. Mehta, J., Kelsey, S., Chu, P., Powels, R., Hazel, D., Riley, U., Evans, C., Newland, A., Treleaven, J. & Singhal, S. (1997) Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies. Bone Marrow Transplantation, 20, 39-43.
26. Menichetti, F., Del Favero, A., Martino, P., Bucaneve, G., Micozzi, A., D'Antonio, D., Ricci, P., Carotenuto, M., Liso, V. & Nosari, A.M. (1994) Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B. The GIMEMA Infection Program. Annals of Internal Medicine, 120, 913-918.
27. Menichetti, F., Del Favero, A., Martino, P., Bucaneve, G., Micozzi, A., Girmenia, C., Barbabietola, G., Pagano, L., Leoni, P., Specchia, G., Catozzo, A., Raimondi, R. & Mandelli, F. (1999) Itraconazole oral solution prophylaxis of fungal infections in neutropenic patients with haematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. Clinical Infectious Diseases, in press.
28. Patterson, J.E., Zidouh, A., Miniter, P., Andriole, V.T. & Patterson, T.F. (1997) Hospital epidemiologic surveillance for invasive aspergillosis: patient demographics and the utility of antigen detection. Infection Control and Hospital Epidemiology, 18, 104-108.
29. Perfect, J.R., Klotman, M.E., Gilbert, C.C., Crawford, D.D., Rosner, G.L., Wright, K.A. & Peters, W.P. (1992) Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. Journal of Infectious Diseases, 165, 891-897.
30. Persat, F., Marzullo, C., Guyotat, D., Rochet, M.-J. & Piens, M.-A. (1992) Plasma itraconazole concentrations in neutropenic patients after repeated high-dose treatment. European Journal of Cancer, 28A, 838-841.
31. Philpott-Howard, J.N., Wade, J.J., Mufti, G.J., Brammer, K.W. & Ehninger, G. (1993) Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Journal of Antimicrobial Chemotherapy, 31, 973-984.
32. Prentice, A.G., Warnock, D.W., Johnson, S.A.N., Phillips, M.J. & Oliver, D.A. (1994) Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients. Journal of Antimicrobial Chemotherapy, 34, 247-252.
33. Prentice, A.G., Warnock, D.W., Johnson, S.A.N., Taylor, P.C. & Oliver, D.A. (1995) Multiple dose pharmacokinetics or an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia. Journal of Antimicrobial Chemotherapy, 36, 657-663.
34. Prentice, A.G., Warnock, D.W., Morgenstern, G.R., Prentice, H.G., Ropner, J.E. & Schey, S.A. (1997) Serum concentrations of itraconazole in neutropenic patients receiving itraconazole/cyclodextrin solution. Blood, 90, (Suppl. 1), 545a.
35. Reents, S., Goodwin, D. & Singh, V. (1993) Antifungal prophylaxis in immunocompromised hosts. Annals of Pharmacotherapy, 27, 53-60.
36. Richardson, M.D. & Kokki, M.H. (1998) Antifungal therapy in 'bone marrow failure'. British Journal of Haematology, 100, 619-628.
37. Riley, D.K., Pavia, A.T., Beatty, P.G., Petersen, F.B., Spruance, J.L., Stokes, R. & Evans, T.G. (1994) The prophylactic use of low-dose amphotericin B in bone marrow transplant patients. American Journal of Medicine, 97, 509-514.
38. Slavin, M.A., Osborne, B., Adams, R., Levenstein, M.J., Schoch, H.G., Feldman, A.R., Meyers, J.D. & Bowden, R.A. (1995) Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation: a prospective, randomized, double-blind study. Journal of Infectious Diseases, 171, 1545-1552.
39. Todeschini, G., Murari, C., Bonesi, R., Pizzolo, G., Amaddi, G., Ambrosetti, A., Ceru, S., Piacentini, I., Martini, N., Montresor, P. & Perona, G. (1993) Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with haematological malignancies. European Journal of Clinical Microbiology and Infectious Diseases, 12, 614-618.
40. Tricot, G., Joosten, E., Boogaerts, M.A., Vande Pitte, J. & Cauwenbergh, G. (1987) Ketoconazole vs itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two non-randomized studies. Reviews of Infectious Diseases, 9, (Suppl. 1), S94-S99.
41. Tsourounis, C. & Guglielmo, B.J. (1996) Aerosolized amphotericin B in prophylaxis of pulmonary aspergillosis. Annals of Pharmacotherapy, 30, 1175-1176.
42. Uzun, O. & Anaissie, F.J. (1995) Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal. Blood, 86, 2063-2072.
43. Verweij, P.E. & Denning, D.W. (1997) Diagnostic and therapeutic strategies for invasive aspergillosis. Seminars in Respiratory and Critical Care Medicine, 18, 203-215.
44. Vreugdenhil, G., Van Dijke, B.J., Donnelly, J.P., Novakova, I.R.O., Raemaekers, J.M.M., Hoogkamp-Korstanje, M.A.A., Kosler, M. & De Pauw, B.E. (1993) Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy: a double-blind, placebo controlled study. Leukemia and Lymphoma, 11, 353-358.
45. Warnock, D.W., Turner, A. & Burke, J. (1988) Comparison of high performance liquid chromatographic and microbiological methods for determination of itraconazole. Journal of Antimicrobial Chemotherapy, 21, 93-100.
46. Winston, D.J., Chandrasekar, P.H., Lazarus, H.M., Goodman, J.L., Silber, J.L., Horowitz, H., Shadduck, R.K., Rosenfeld, C.S., Ho, W.G., Islam, M.Z. & Buell, D.N. (1993) Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Annals of Internal Medicine, 118, 495-503.